I'm really optimistic about Neurocrine Biosciences (NBIX) as it shows strong growth and profitability in the biopharmaceutical space. With their expan...
Read
More
I'm really optimistic about Neurocrine Biosciences (NBIX) as it shows strong growth and profitability in the biopharmaceutical space. With their expanding pipeline and recent partnership revisions, I believe there's significant upside ahead, definitely more than the projected 10% increase. I'm planning to add some shares to my portfolio.
I believe Neurocrine Biosciences is in a strong position, especially with its successful schizophrenia treatments and profitability. Given the growing...
Read
More
I believe Neurocrine Biosciences is in a strong position, especially with its successful schizophrenia treatments and profitability. Given the growing market for mental health medications, I'm confident that holding shares could lead to significant gains as the company continues to develop its pipeline and may potentially attract acquisition interest.